Friday, January 28, 2022
Helius Medical Technologies (HSDT)(HSM:CA)
Terminating Research Coverage
Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain’s ability to heal itself. The Company’s first commercial product is the Portable Neuromodulation Stimulator (PoNSTM). For more information, visit www.heliusmedical.com.
Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.
Gregory Aurand, Senior Research Analyst, Noble Capital Markets, Inc.
Termination of Research Coverage. We are terminating research coverage of Helius Medical Technologies due to a reallocation of resources. Effective upon termination of coverage, investors should no longer rely on any of our prior research, financial estimates, or ratings for the Company.
This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.
